应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02616 基石药业-B
未开盘 02-24 16:08:09
6.360
+0.310
+5.12%
最高
6.470
最低
6.020
成交量
1,213万
今开
6.050
昨收
6.050
日振幅
7.44%
总市值
93.87亿
流通市值
93.87亿
总股本
14.76亿
成交额
7,642万
换手率
0.82%
流通股本
14.76亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
基石药业-B02月24日主力净流入732.5万元 散户资金抛售
市场透视 · 02-24 16:15
基石药业-B02月24日主力净流入732.5万元 散户资金抛售
港股基石药业-B涨超5%
每日经济新闻 · 02-24 10:50
港股基石药业-B涨超5%
港股异动 | 基石药业-B(02616)涨超5% 舒格利单抗III期非小细胞肺癌新适应症获英国MHRA批准
智通财经 · 02-24 10:30
港股异动 | 基石药业-B(02616)涨超5% 舒格利单抗III期非小细胞肺癌新适应症获英国MHRA批准
每日卖空追踪 | 基石药业-B 02月23日卖空量成交64.95万股,卖空比例为8.3%
市场透视 · 02-23 16:30
每日卖空追踪 | 基石药业-B 02月23日卖空量成交64.95万股,卖空比例为8.3%
基石药业-B02月23日主力净流出192.4万元 散户资金买入
市场透视 · 02-23 16:15
基石药业-B02月23日主力净流出192.4万元 散户资金买入
基石药业-B(02616):舒格利单抗III期小细胞肺癌新适应症获英国MHRA批准
智通财经网 · 02-23 08:17
基石药业-B(02616):舒格利单抗III期小细胞肺癌新适应症获英国MHRA批准
每日卖空追踪 | 基石药业-B 02月20日卖空量成交117.55万股,卖空比例为9.86%
市场透视 · 02-20
每日卖空追踪 | 基石药业-B 02月20日卖空量成交117.55万股,卖空比例为9.86%
IO2.0争夺战打响,下一代肿瘤“药王”花落谁家?
药创新 · 02-20
IO2.0争夺战打响,下一代肿瘤“药王”花落谁家?
基石药业-B盘中异动 早盘急速拉升5.08%
市场透视 · 02-20
基石药业-B盘中异动 早盘急速拉升5.08%
基石药业-B(02616)CS2009(PD-1/VEGF/CTLA-4三特异性抗体)II期临床试验申请获美国FDA批准
智通财经 · 02-20
基石药业-B(02616)CS2009(PD-1/VEGF/CTLA-4三特异性抗体)II期临床试验申请获美国FDA批准
每日卖空追踪 | 基石药业-B 02月16日卖空量成交96.5万股,卖空比例为31.82%
市场透视 · 02-16
每日卖空追踪 | 基石药业-B 02月16日卖空量成交96.5万股,卖空比例为31.82%
基石药业-B(02616):CS2009(PD-1/VEGF/CTLA-4三特异性抗体)II期临床试验申请获美国FDA批准
智通财经 · 02-16
基石药业-B(02616):CS2009(PD-1/VEGF/CTLA-4三特异性抗体)II期临床试验申请获美国FDA批准
每日卖空追踪 | 基石药业-B 02月13日卖空量成交114.7万股,卖空比例为9.14%
市场透视 · 02-13
每日卖空追踪 | 基石药业-B 02月13日卖空量成交114.7万股,卖空比例为9.14%
基石药业-B02月13日获主力加仓572.2万元
市场透视 · 02-13
基石药业-B02月13日获主力加仓572.2万元
每日卖空追踪 | 基石药业-B 02月12日卖空量成交185.95万股,卖空比例为25.55%
市场透视 · 02-12
每日卖空追踪 | 基石药业-B 02月12日卖空量成交185.95万股,卖空比例为25.55%
基石药业-B02月10日主力净流入322.7万元 散户资金抛售
市场透视 · 02-10
基石药业-B02月10日主力净流入322.7万元 散户资金抛售
每日卖空追踪 | 基石药业-B 02月09日卖空量成交97.05万股,卖空比例为17.89%
市场透视 · 02-09
每日卖空追踪 | 基石药业-B 02月09日卖空量成交97.05万股,卖空比例为17.89%
基石药业-B(02616):联交所确认倪维聪担任公司秘书的资格
智通财经网 · 02-06
基石药业-B(02616):联交所确认倪维聪担任公司秘书的资格
每日卖空追踪 | 基石药业-B 02月06日卖空量成交110.15万股,卖空比例为20.25%
市场透视 · 02-06
每日卖空追踪 | 基石药业-B 02月06日卖空量成交110.15万股,卖空比例为20.25%
每日卖空追踪 | 基石药业-B 02月05日卖空量成交118.9万股,卖空比例为19.45%
市场透视 · 02-05
每日卖空追踪 | 基石药业-B 02月05日卖空量成交118.9万股,卖空比例为19.45%
公司概况
公司名称:
基石药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
基石药业是一家主要从事肿瘤、自身免疫和炎症及其他关键疾病领域药物研发及销售的投资控股公司。该公司通过其子公司主要从事生物制药产品的研发、药品的销售及提供其知识产权(IP)授权或商业化授权。该公司产品主要包括精准治疗药物“泰吉华”(阿伐替尼)及“普吉华”(普拉替尼)、以及“择捷美”(舒格利单抗)等。该公司还从事肿瘤免疫药物的开发及商业化。该公司主要在中国国内市场、以及中欧、东欧和瑞士等海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02616","market":"HK","secType":"STK","nameCN":"基石药业-B","latestPrice":6.36,"timestamp":1771920489007,"preClose":6.05,"halted":0,"volume":12133000,"delay":0,"changeRate":0.05123966942148769,"floatShares":1476000000,"shares":1476000000,"eps":-0.071467,"marketStatus":"未开盘","change":0.31,"latestTime":"02-24 16:08:09","open":6.05,"high":6.47,"low":6.02,"amount":76421674,"amplitude":0.07438,"askPrice":6.36,"askSize":1675000,"bidPrice":6.34,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":-0.28,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771983000000},"marketStatusCode":0,"adr":0,"listingDate":1551110400000,"exchange":"SEHK","adjPreClose":6.05,"openAndCloseTimeList":[[1771896600000,1771905600000],[1771909200000,1771920000000]],"volumeRatio":1.2684953008079871,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02616/wiki","defaultTab":"wiki","newsList":[{"id":"2613796954","title":"基石药业-B02月24日主力净流入732.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796954","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613796954?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920945,"startTime":"0","endTime":"0","summary":"02月24日, 基石药业-B股价涨5.12%,报收6.36元,成交金额7642.2万元,换手率0.82%,振幅7.44%,量比1.26。基石药业-B今日主力资金净流入732.5万元,上一交易日主力净流出192.4万元。该股近5个交易日上涨14.98%,主力资金累计净流入2719.8万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入7324.2万元,其中净流入天数为17日。该股主力净额占比0.08%,港股市场排名83/2720。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161941a4c22511&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161941a4c22511&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1574","BK1161"],"gpt_icon":0},{"id":"2613750044","title":"港股基石药业-B涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613750044","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613750044?lang=zh_cn&edition=full","pubTime":"2026-02-24 10:50","pubTimestamp":1771901446,"startTime":"0","endTime":"0","summary":"每经AI快讯,基石药业-B(02616.HK)涨超5%,截至发稿,涨5.12%,报6.36港元,成交额2393.21万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602243652474013.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602243652474013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","VT","BK1574","VXUS","BK4585","BK1161","02616"],"gpt_icon":0},{"id":"2613750586","title":"港股异动 | 基石药业-B(02616)涨超5% 舒格利单抗III期非小细胞肺癌新适应症获英国MHRA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2613750586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613750586?lang=zh_cn&edition=full","pubTime":"2026-02-24 10:30","pubTimestamp":1771900210,"startTime":"0","endTime":"0","summary":"消息面上,基石药业昨日公布,舒格利单抗的新适应症申请已获英国药品和医疗保健用品管理局批准单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因数受体敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期小细胞肺癌成人患者。继欧盟委员会批准后,舒格利单抗III期NSCLC新适应症再获英国MHRA批准,这是该产品在英国获得的第二个适应症批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK4585","BK4588","BK4134","BK1574","VT","02616","BK1161","III"],"gpt_icon":0},{"id":"2613624657","title":"每日卖空追踪 | 基石药业-B 02月23日卖空量成交64.95万股,卖空比例为8.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613624657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613624657?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835432,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月23日,跌2.1%,卖空量成交64.95万股,较上一交易日减少65.1%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163423a4be7df5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163423a4be7df5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2613624417","title":"基石药业-B02月23日主力净流出192.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613624417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613624417?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:15","pubTimestamp":1771834544,"startTime":"0","endTime":"0","summary":"02月23日, 基石药业-B股价跌2.10%,报收6.05元,成交金额4851.1万元,换手率0.53%,振幅6.63%,量比0.74。基石药业-B今日主力资金净流出192.4万元,上一交易日主力净流入170.5万元。该股近5个交易日上涨8.04%,主力资金累计净流入3129.0万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入6476.3万元,其中净流入天数为16日。该股主力净额占比0.02%,港股市场排名2615/2717。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161840a71559c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161840a71559c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2613027209","title":"基石药业-B(02616):舒格利单抗III期小细胞肺癌新适应症获英国MHRA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2613027209","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613027209?lang=zh_cn&edition=full","pubTime":"2026-02-23 08:17","pubTimestamp":1771805849,"startTime":"0","endTime":"0","summary":"基石药业-B(02616)发布公告,舒格利单抗的新适应症申请已获英国药品和医疗保健用品管理局(MHRA)批准单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因数受体(EGFR)敏感突变或ALK、ROS1基因组变异、在含铂放化疗(CRT)后未出现疾病进展的、不可切除的III期小细胞肺癌(NSCLC)成人患者。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["III","BK1161","02616","BK1574","BK4134"],"gpt_icon":0},{"id":"2613292895","title":"每日卖空追踪 | 基石药业-B 02月20日卖空量成交117.55万股,卖空比例为9.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613292895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613292895?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576231,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月20日,涨4.57%,卖空量成交117.55万股,较上一交易日增加21.81%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163423a4b5e8f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163423a4b5e8f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2612252506","title":"IO2.0争夺战打响,下一代肿瘤“药王”花落谁家?","url":"https://stock-news.laohu8.com/highlight/detail?id=2612252506","media":"药创新","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612252506?lang=zh_cn&edition=full","pubTime":"2026-02-20 15:00","pubTimestamp":1771570819,"startTime":"0","endTime":"0","summary":"下一代肿瘤“药王”争夺战打响!撰文丨粽哥2025下一代肿瘤“药王”,极有可能诞生于PD-1+X领域。以K药为代表的PD-1单抗,开启了一代IO治疗时代,但却存在耐药和冷肿瘤缺乏应答的问题。临床上,T细胞耗竭现象是导致免疫检查点获得性耐药的关键机制。TIGIT是经典免疫逃逸靶点,在多种淋巴细胞上表达,被认为是“下一个PD-1”。不过,PD-1/TIGIT双抗或有望打破TIGIT“难以成药”的魔咒。TIGIT和PD-1表达之间存在很强的相关性,特别是在肺癌的肿瘤浸","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602201513389541818d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602201513389541818d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348783233.USD","LU1720050803.USD","IE00B5MMRT66.SGD","LU0417516738.SGD","02696","LU0417516571.SGD","LU1961090484.USD","LU0417516902.SGD","IE00B543WZ88.USD","09926","BK1574","LU2399975544.HKD","01530","LU1794554557.SGD","LU2488822045.USD","01801","LU2778985437.USD","LU0348827113.USD","LU0348767384.USD","LU0348766576.USD","01877","LU0348784397.USD","BK1161","IE00BPRC5H50.USD","LU0634319403.HKD","LU2476274720.SGD","LU0348825331.USD","LU0540923850.HKD","LU2476274308.USD","09995","LU0348735423.USD","LU0561508036.HKD","01177","02898","02616","09887"],"gpt_icon":1},{"id":"2613817292","title":"基石药业-B盘中异动 早盘急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613817292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613817292?lang=zh_cn&edition=full","pubTime":"2026-02-20 10:31","pubTimestamp":1771554702,"startTime":"0","endTime":"0","summary":"2026年02月20日早盘10时31分,基石药业-B股票出现波动,股价快速拉升5.08%。截至发稿,该股报6.210港元/股,成交量407.9万股,换手率0.28%,振幅6.60%。机构评级方面,在所有2家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。其相关个股中,永泰生物-B、基石药业-B、百济神州涨幅较大,振幅较大的相关个股有来凯医药-B、中慧生物-B、诺诚健华,振幅分别为9.44%、8.44%、7.72%。该公司还从事肿瘤免疫药物的开发及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022010314295417e18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022010314295417e18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2612230016","title":"基石药业-B(02616)CS2009(PD-1/VEGF/CTLA-4三特异性抗体)II期临床试验申请获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2612230016","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612230016?lang=zh_cn&edition=full","pubTime":"2026-02-20 10:18","pubTimestamp":1771553881,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,基石药业-B宣布公司核心资产CS2009用于晚期实体瘤的II期临床试验IND申请已经获得FDA批准。CS2009用于晚期实体瘤的II期新药临床试验申请获美国食品药品监督管理局批准,标志着这一创新免疫疗法的全球开发取得重要进展。基石药业首席执行官、研发总裁及执行董事杨建新博士表示,非常高兴能够看到CS2009的全球多中心II期临床试验高效推进并获美国FDA批准开展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU1169589451.USD","BK1574","PD","BK4023","LU1169590202.USD","02616"],"gpt_icon":0},{"id":"2612943825","title":"每日卖空追踪 | 基石药业-B 02月16日卖空量成交96.5万股,卖空比例为31.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612943825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612943825?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230629,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月16日,跌0.17%,卖空量成交96.5万股,较上一交易日减少61.24%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163413a700dfa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163413a700dfa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1161","BK1574"],"gpt_icon":0},{"id":"2611171921","title":"基石药业-B(02616):CS2009(PD-1/VEGF/CTLA-4三特异性抗体)II期临床试验申请获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2611171921","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611171921?lang=zh_cn&edition=full","pubTime":"2026-02-16 08:08","pubTimestamp":1771200501,"startTime":"0","endTime":"0","summary":"智通财经APP讯,基石药业-B 发布公告,公司核心资产CS2009用于晚期实体瘤的II期新药临床试验申请已经获得美国食品药品监督管理局批准。CS2009的I期临床研究初步数据已在2025年欧洲肿瘤内科学会年会上公布,安全性与耐受性良好,抗肿瘤活性数据积极。更多I期和II期临床研究数据预计将在今年召开的美国临床肿瘤学会和ESMO会议上公布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1169589451.USD","02616","LU1169590202.USD","PD","BK1161","BK4023","BK1574"],"gpt_icon":0},{"id":"2611199870","title":"每日卖空追踪 | 基石药业-B 02月13日卖空量成交114.7万股,卖空比例为9.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611199870","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611199870?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971434,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月13日,涨6.86%,卖空量成交114.7万股,较上一交易日减少68.39%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163459a6f6e5f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163459a6f6e5f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1574","BK1161"],"gpt_icon":0},{"id":"2611821199","title":"基石药业-B02月13日获主力加仓572.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611821199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611821199?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:15","pubTimestamp":1770970518,"startTime":"0","endTime":"0","summary":"02月13日, 基石药业-B股价涨6.86%,报收5.92元,成交金额7224.4万元,换手率0.85%,振幅10.47%,量比1.53。基石药业-B今日主力资金净流入572.2万元,连续4日净流入,上一交易日主力净流入1436.9万元。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为40.00%,平均涨幅为5.59%。该股近5个交易日上涨16.54%,主力资金累计净流入3373.6万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入5604.4万元,其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161603a49fe4bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161603a49fe4bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2611397675","title":"每日卖空追踪 | 基石药业-B 02月12日卖空量成交185.95万股,卖空比例为25.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611397675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611397675?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:30","pubTimestamp":1770885033,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月12日,跌1.07%,卖空量成交185.95万股,较上一交易日减少29%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163446a6f28d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163446a6f28d09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02616"],"gpt_icon":0},{"id":"2610533600","title":"基石药业-B02月10日主力净流入322.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610533600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610533600?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:15","pubTimestamp":1770711338,"startTime":"0","endTime":"0","summary":"02月10日, 基石药业-B股价涨3.11%,报收5.30元,成交金额5623.3万元,换手率0.72%,振幅5.25%,量比1.50。基石药业-B今日主力资金净流入322.7万元,上一交易日主力净流出100.0万元。该股近5个交易日上涨0.38%,主力资金累计净流入1045.4万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入2164.0万元,其中净流入天数为12日。该股主力净额占比0.04%,港股市场排名162/2717。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161816a492a619&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161816a492a619&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2610266020","title":"每日卖空追踪 | 基石药业-B 02月09日卖空量成交97.05万股,卖空比例为17.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610266020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610266020?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625832,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月09日,涨1.18%,卖空量成交97.05万股,较上一交易日减少54.18%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163908a48e5d91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163908a48e5d91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2609561159","title":"基石药业-B(02616):联交所确认倪维聪担任公司秘书的资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2609561159","media":"智通财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609561159?lang=zh_cn&edition=full","pubTime":"2026-02-06 18:16","pubTimestamp":1770373019,"startTime":"0","endTime":"0","summary":"基石药业-B(02616)发布公告,联交所已确认,联席公司秘书倪维聪女士(倪女士)于2026年1月17日豁免届满后符合上市规则第3.28条项下担任本公司公司秘书的资格。因此,翁美仪女士(翁女士)已辞任联席公司秘书一职,自2026年2月6日起生效。翁女士辞任后,倪女士继续担任本公司唯一公司秘书。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_7.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_7.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02616","BK1161","BK1574"],"gpt_icon":0},{"id":"2609431045","title":"每日卖空追踪 | 基石药业-B 02月06日卖空量成交110.15万股,卖空比例为20.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609431045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609431045?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366634,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月06日,跌1.93%,卖空量成交110.15万股,较上一交易日减少48.14%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163522a483cfdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163522a483cfdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2609301736","title":"每日卖空追踪 | 基石药业-B 02月05日卖空量成交118.9万股,卖空比例为19.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609301736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609301736?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:30","pubTimestamp":1770280232,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间02月05日,跌2.63%,卖空量成交118.9万股,较上一交易日减少56.84%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205163623a47f62a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205163623a47f62a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cstonepharma.com","stockEarnings":[{"period":"1week","weight":0.0761},{"period":"1month","weight":0.1257},{"period":"3month","weight":0.0707},{"period":"6month","weight":-0.3837},{"period":"1year","weight":1.0516},{"period":"ytd","weight":0.2068}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.006},{"period":"3month","weight":0.0255},{"period":"6month","weight":0.0637},{"period":"1year","weight":0.1392},{"period":"ytd","weight":0.0374}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"基石药业是一家主要从事肿瘤、自身免疫和炎症及其他关键疾病领域药物研发及销售的投资控股公司。该公司通过其子公司主要从事生物制药产品的研发、药品的销售及提供其知识产权(IP)授权或商业化授权。该公司产品主要包括精准治疗药物“泰吉华”(阿伐替尼)及“普吉华”(普拉替尼)、以及“择捷美”(舒格利单抗)等。该公司还从事肿瘤免疫药物的开发及商业化。该公司主要在中国国内市场、以及中欧、东欧和瑞士等海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.050688},{"month":2,"riseRate":0.428571,"avgChangeRate":0.060585},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.10478},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.048094},{"month":5,"riseRate":0.5,"avgChangeRate":0.100514},{"month":6,"riseRate":0.714286,"avgChangeRate":0.09443},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05639},{"month":8,"riseRate":0.428571,"avgChangeRate":0.079119},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.071005},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.012196},{"month":11,"riseRate":0.571429,"avgChangeRate":0.010396},{"month":12,"riseRate":0.428571,"avgChangeRate":0.004524}],"exchange":"SEHK","name":"基石药业-B","nameEN":"CSTONE PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基石药业-B,02616,基石药业-B股票,基石药业-B股票老虎,基石药业-B股票老虎国际,基石药业-B行情,基石药业-B股票行情,基石药业-B股价,基石药业-B股市,基石药业-B股票价格,基石药业-B股票交易,基石药业-B股票购买,基石药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}